Related references
Note: Only part of the references are listed.Glucocorticoid Regulates Interleukin-37 in Systemic Lupus Erythematosus
Lijun Song et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Serum Interleukin-37 Concentrations and HBeAg Seroconversion in Chronic HBV Patients During Telbivudine Treatment
Cong Li et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2013)
Elevated Levels of Cerebrospinal Fluid and Plasma Interleukin-37 in Patients with Guillain-Barre Syndrome
Cong Li et al.
MEDIATORS OF INFLAMMATION (2013)
Thymic Stromal Lymphopoietin Attenuates the Development of Atherosclerosis in ApoE-/- Mice
Kunwu Yu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells
Nozomu Sakai et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Decreased Plasma IL-35 Levels Are Related to the Left Ventricular Ejection Fraction in Coronary Artery Diseases
Yingzhong Lin et al.
PLOS ONE (2012)
Immunotherapy With Tolerogenic Apolipoprotein B-100-Loaded Dendritic Cells Attenuates Atherosclerosis in Hypercholesterolemic Mice
Andreas Hermansson et al.
CIRCULATION (2011)
Interleukin 37 expression protects mice from colitis
Eoin N. McNamee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
IL-37: a new anti-inflammatory cytokine of the IL-1 family
Diana Boraschi et al.
EUROPEAN CYTOKINE NETWORK (2011)
Interleukin-18 as a Predictor of Future Events in Patients With Acute Coronary Syndromes
Marianne Hartford et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
IL-37 is a fundamental inhibitor of innate immunity
Marcel F. Nold et al.
NATURE IMMUNOLOGY (2010)
IL-33 is a crucial amplifier of innate rather than acquired immunity
Keisuke Oboki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Downregulation of T Helper Cell Type 3 in Patients with Acute Coronary Syndrome
Qing-wei Ji et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
Conventional Dendritic Cells at the Crossroads Between Immunity and Cholesterol Homeostasis in Atherosclerosis
Emmanuel L. Gautier et al.
CIRCULATION (2009)
Interleukin-17 and Interferon-γ Are Produced Concomitantly by Human Coronary Artery-Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle Cells
Raymond E. Eid et al.
CIRCULATION (2009)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines
Sheetal Sharma et al.
JOURNAL OF IMMUNOLOGY (2008)
N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission
Michael Weber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
T cells in atherogenesis - For better or for worse?
Anna-Karin L. Robertson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction
Young-Guk Ko et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Local release of C-reactive protein from vulnerable plaque or coronary arterial wall in injured by stenting
T Inoue et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes
H Methe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice
F Merhi-Soussi et al.
CARDIOVASCULAR RESEARCH (2005)
Inflammatory markers at the site of ruptured plaque in acute myocardial infarction -: Locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein
W Maier et al.
CIRCULATION (2005)
N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease
C Kragelund et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice
R de Nooijer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Interleukin-18 and interleukin-18 binding protein levels before and after percutaneous coronary intervention in patients with and without recent myocardial infarction
CR Narins et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques
A Aggarwal et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice
R Elhage et al.
CARDIOVASCULAR RESEARCH (2003)
Lack of interleukin-1β decreases the severity of atherosclerosis in ApoE-deficient mice
H Kirii et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein
NK Banda et al.
JOURNAL OF IMMUNOLOGY (2003)
Increased plasma concentrations of interleukin-18 in acute coronary syndromes
Z Mallat et al.
HEART (2002)
A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity
P Bufler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Genomic organization of the interleukin-1 locus
SL Taylor et al.
GENOMICS (2002)
Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability
Z Mallat et al.
CIRCULATION (2001)
Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability
Z Mallat et al.
CIRCULATION RESEARCH (2001)
IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp
GH Pan et al.
CYTOKINE (2001)
Share Paper
